Quarterly Report • Oct 27, 2015
Quarterly Report
Open in ViewerOpens in native device viewer
| Jul-Sep | Jan-Sep | Rolling 12 | Full year | |||
|---|---|---|---|---|---|---|
| (SEK Million) | 2015 | 2014 | 2015 | 2014 | months | 2014 |
| Net sales | 88,1 | 81,9 | 277,9 | 245,1 | 375,3 | 342,4 |
| whereof recurring revenue | 43,6 | 40,6 | 131,2 | 118,4 | 171,4 | 158,7 |
| EBITDA | 19,3 | 17,5 | 60,6 | 49,3 | 89,5 | 78,2 |
| EBIT - excluding one-off items | 6,2 | 6,0 | 22,0 | 17,8 | 38,9 | 34,6 |
| EBIT | 2,7 | 5,3 | 18,5 | 16,7 | 35,3 | 33,5 |
The third quarter offered both successes and setbacks, where some areas are stronger than ever and continues to perform well, while in other areas we see challenges. On the positive side, sales to the Swedish public sector was our best ever for a third quarter, and orders for our newly launched product for mobile meeting's management already came in from existing municipal customers, as an add-on to the products Acadre in Denmark and W3D3 and Platina in Sweden.
The area where we see the biggest challenge is in our consultancy organization for customer specific solutions offered to Danish authorities. The reasons for this being a lost framework agreement for our largest customer in the region, as well as general price pressure regarding rates for this kind of consulting services. Because of this we have decided to launch a restructuring program with the aim to scale down this part of our business. The decision is in line with our strategy of being a software company, and consequently only offer consulting services related to our own products.
Historically, our general consulting services have experienced both volatile sales and profitability. In 2014 this part of our business contributed around 10% of net sales and showed a profitability in line with the business in general. Looking ahead, we believe that these revenues will be cut by half on an annual basis. This change creates more predictable and steady revenues and costs, which is more in line with our other business. With the above restructuring work, we have carried out a general review of our operations in Denmark with the aim of increasing efficiency. The total costs for the restructuring program, including cost commitments up to first quarter of 2016, amounts to SEK 3.5 million and has been recorded in full in the third quarter.
In the Life Science area, we continue to increase our investment in the US where we already received a good impact regarding our products. This increased investment means we still have some way to go before we reach profitability for the entire business area, which by now have already been achieved for the European part of the Life Science business.
We are now entering the fourth quarter, which is usually the strongest of the year and we expect that it will be this year too.
Formpipe receives a contract from a US Life Science company, the total order value amounts to approximately SEK 1 million over three years.
The Danish ministry of health and Formpipe signs a contract for the Grant Management product TAS. The total order value amounts to SEK 1.5 million for a duration of four years.
Formpipe receives order on the ECM product Platina from The Swedish Prison and Probation Service. The total order value amounts to SEK 3.3 million.
Formpipe receives an order for Long-Term Archive from a Swedish authority. The total order value amounts to SEK 1.1 million.
Formpipe focuses its offerings on the public sector in Sweden and Denmark, in the international market on the Life Sciences industry and Legal sector and on industry independent offerings in respect of input/output management. According to the Radar Group, ECM continues to be a high priority investment area for companies and organizations.
Greater regulatory requirements and effective information management as a means of competition are important driving forces that have a tendency to be continually strengthened in connection with the increased amount of information.
According to analysts at Radar Group, ECM continues to be a high-priority investment area for the public sector. According to Radar, the ECM market for the public sector in Sweden will see growth of 5.1 (3.0) per cent, with an equivalent figure for Denmark of 4.3 (2.8) per cent.
The ECM market for public sector is less sensitive to market fluctuations than other sectors since they have a continuous need to invest in effective e-government solutions. Shrinking younger age groups must support a growing senior age group, while rising living standards are still expected. Public administration is facing major cost driving challenges and changes in fields such as digitisation and streamlining of operations, accessibility and service via the web and reduced costs for production of standardised IT. Both Formpipe and external analysts estimate that the need for efficient administration will lead to continued investments by the public sector in existing or new ECM systems. The number of public agencies that have a budget for ECM will also increase from year to year. The trend points to reducing operational costs through initiatives like outsourcing, so that resources are freed up for e-administration development. As part of this trend, investments are increasingly being financed through operating budgets. ECM solutions have evolved from being an IT issue to becoming a strategic business issue.
Public administrations in Europe are facing the challenge of improving efficiency, productivity and the quality of their services. All these challenges must though be met with unchanged or even reduced budgets. Information and communication technology helps the public sector to handle challenges such as:
Formpipe currently has customers in a number of European countries, as well as in the USA, regarding products and services for quality management and regulatory compliance. Like the public sector, the Life Sciences Industry has strict regulatory requirements. The market is strictly regulated by the national regulations of the market that the product or service is to be submitted to (in the US the regulator is the Food and Drug Administration (FDA), in the European Union it is the EMEA, etc).
It is estimated that the market for ECM products for the Life Sciences industry will grow strongly among mediumsized enterprises (200-1,000 users), as these are starting to use the same efficiency-enhancing tools as the major, traditional pharmaceutical companies. The major companies (more than 1,000 users) are seeing a trend towards replacing several different local systems with integrated turnkey solutions which provide a better overview and reduce administration and maintenance costs. It is thought that the market for EQMS products for Life Sciences companies' subcontractors will also grow, as they need to comply with the industry's regulations on account of the fact that they are increasingly playing a key role in the delivery and supply chain.
Formpipe's offering regarding input and output management, Lasernet, is essentially linked to the ERP market. The software is used for designing, converting and distributing business documents with data retrieved directly from any ERP system and it has more than 2,000 customers within a variety of industries all over the world.
Formpipe focuses on further reinforcing its offering for customers implementing Microsoft Dynamics, currently one of the fastest-growing ERP systems on the market. Formpipe has a well-developed partnership with a number of key partners in countries such as the Netherlands,
Germany, Denmark and Sweden, and as a result it is able to benefit from the major sales successes for Microsoft Dynamics.
Formpipe is a leading supplier of ECM solutions in Sweden and Denmark. The board considers that the company is well-positioned to be able to develop and strengthen its leading position while retaining good profitability levels. The company sees good opportunities to continue to utilize its experience from its successes within the public sector in Sweden and Denmark, which from an international perspective are considered models for efficient public administration, in order to target new markets and customer segments. With well-invested products, solid experience of the public sector and facilities for continued product development, the company sees opportunities to focus on the demand at EU level which with increased regulatory requirements can be expected to increase its investments in the coming years. In addition to the Swedish public sector, Formpipe Software also focuses on the life science sector, which like the public sector is a segment that is strictly regulated by regulatory requirements. The Company has developed a competitive offering to this sector. The life science market is faced with the same regulatory requirements regardless of geographical location, which creates a very large international market. The company's strategy with focus on the public sector and Life Science creates good opportunities to be able to efficiently develop market-leading offerings and need sector-specific requirements.
The board believes that Formpipe, which is one of the largest European-based ECM suppliers, is well-positioned with a stabile customer base, a high share of recurring revenue and a focus on customer segments with a high need for ECM solutions. At the same time, the board considers that the ECM market is a sector undergoing consolidation and views acquisitions as a good complement to organic growth.
Net sales for the period totaled SEK 88.1 million (81.9 million), which corresponds to an increase of 8 %. System revenue increased by 13 % from the previous year and totaled SEK 57.8 million (51.1 million). Total recurring revenue for the period increased by 7 % from the previous year and totaled SEK 43.6 million (40.6 million), which is equivalent to 49 % of net sales. Exchange rate effects have affected net sales positively by SEK 1.8 million in comparison with the previous year.
Net sales for the period totaled SEK 277.9 million (245.1 million), which corresponds to an increase of 13 %. System revenue increased by 15 % from the previous year and totaled SEK 178.6 million (155.2 million). Total recurring revenue for the period increased by 11 % from the previous year and totaled SEK 131.2 million (118.4 million), which is equivalent to 47 % of net sales. Exchange rate effects have affected net sales positively by SEK 5.9 million in comparison with the previous year.
Recurring revenue rolling 12-month, SEKm
The operating costs for the period increased by 14 % and totaled SEK 85.4 million (76.6 million). Personnel costs increased by 14 % and totaled SEK 51.2 million (44.7 million). Selling expenses totaled SEK 12.6 million (13.2 million). Other costs totaled SEK 16.6 million (15.4 million). One-off restructuring costs amounting to 3.5 million (- million) are charging the period.
The operating costs for the period increased by 14 % and totaled SEK 259.5 million (228.5 million). Personnel costs increased by 16 % and totaled SEK 162.1 million (140.1 million). Selling expenses totaled SEK 36.8 million (35.8 million). Other costs totaled SEK 51.5 million (45.8 million). One-off restructuring costs amounting to 3.5 million (- million) are charging the period.
Operating profit before depreciation and amortization and one-off costs (EBITDA) totaled SEK 19.3 million (17.5 million) with an EBITDA margin of 21.9 % (21.3 %). Operating profit (EBIT) totaled SEK 2.7 million (5.3 million) with an operating margin of 3.1 % (6.5 %). One-off restructuring costs amounting to 3.5 million (- million) are charging the period. Net profit totaled SEK 1.8 million (2.0 million). Exchange rate effects have affected EBITDA positively by SEK 0.3 million in comparison with the previous year.
Operating profit before depreciation and amortization and one-off costs (EBITDA) totaled SEK 60.6 million (49.3 million) with an EBITDA margin of 21.8 % (20.1 %). Operating profit (EBIT) totaled SEK 18.5 million (16.7 million) with an operating margin of 6.7 % (6.8 %). Oneoff restructuring costs amounting to 3.5 million (- million) are charging the period. Net profit totaled SEK 10.3 million (7.9 million). Exchange rate effects have affected EBITDA positively by SEK 1.2 million in comparison with the previous year.
Cash and cash equivalents at the end of the period amounted to SEK 15.6 million (6.8 million). The company had interest-bearing debt at the end of the period totaling SEK 124.8 (147.2) million. The company's net interestbearing debt thereby totaled SEK 109.2 million (140.3 million).
The company has bank overdraft facilities for a total of SEK 10.0 million and for DKK 17.0 million, which were not utilized at the end of the period (- million).
By the end of the period the company's deferred tax assets attributable to accumulated losses amounted to SEK 23.6 million (SEK 30.2 million).
Equity at the end of the period amounted to SEK 316.1 million (287.5 million), which was equivalent to SEK 6.30 (5.73) per outstanding share at the end of the period. The strengthening of the Swedish krona has reduced the value of the group's net assets in foreign currencies by SEK -1.8 million (7.8 million) from the end of the year.
The equity ratio at the end of the period was 50 % (47 %).
CASH FLOW FROM OPERATING ACTIVITIES Cash flow from operating activities for the period January - September totaled SEK 39.4 million (31.6 million).
Total investments for the period January - September amounted to SEK 34.8 million (35.4 million), of which investments affecting cash flow totaled SEK 32.0 million (30.3 million).
Investments in intangible assets totaled SEK 33.4 million (26.5 million) and refer to capitalized product development costs.
Investments in tangible assets totaled SEK 1.4 million (1.6 million).
During the period January – September the company has amortized SEK 18.2 million (15.4 million) and the interest-bearing debt amounted to SEK 124.8 million (147.2 million) at the end of the period.
The number of employees at the end of the reporting period totaled 256 persons (240 persons).
The significant risk and uncertainty factors for the group and the parent company, which include business and financial risks, are described in the annual report for the last financial year. During the period there have been no changes in the risk and uncertainty factors for the group and the parent company.
No transactions with related parties have occurred during the period
The group's financial reports are prepared in accordance with International Financial Reporting Standards (IFRS)
in the way in which they have been adopted by the European Union, the Swedish Annual Accounts Act, RFR 1 Additional Accounting Regulations for Groups issued by the Swedish Financial Reporting Board and in accordance with the regulations that the Stockholm Stock Exchange stipulates for companies listed on Nasdaq Stockholm. Preparing financial reports in accordance with IFRS requires that the company management makes accounting evaluations and estimates and makes assumptions that affect the application of the accounting policies and the reported values of assets, liabilities, income and costs. The actual result can differ from these estimates and evaluations. This interim report has been prepared in accordance with IAS 34 Interim Financial Reporting and the Swedish Annual Accounts Act. The most important accounting policies according to IFRS, which constitute the accounting standard for the preparation of this interim report, are stated in the company's most recently published annual report. The financial reports of the parent company have been pre-pared in accordance with the Swedish Annual Accounts Act and RFR 2 Accounting for Legal Entities issued by the Swedish Financial Reporting Board. The same accounting policies and methods of calculation have been applied in the interim report and in the most recent annual report.
Formpipe Software AB (publ) is a software company in the field of ECM (Enterprise Content Management). We develop and deliver ECM products for structuring information in larger companies, the public sector and organizations. Our software helps organizations to capture and place information in context. Reduced costs, minimized risk exposure and structured information are the benefits from using our ECM products.
Formpipe was founded in 2004 and has offices in Sweden, Denmark, United Kingdom, the Netherlands and USA. The Formpipe share is listed on Nasdaq Stockholm.
| February 10, 2016 | Interim report Jan-Dec |
|---|---|
| April 19, 2016 | Interim report Jan-Mar |
| April 21, 2016 | Annual General Meeting |
| July 12, 2016 | Interim report Jan-Jun |
| October 25, 2016 | Interim report Jan-Sep |
This interim report has not been subject to review by the company's auditors.
Can be ordered from the below contact details. All financial information is published on www.formpipe.com immediately after being made public.
Christian Sundin, Managing Director Telephone: +46 70 567 73 85, +46 8 555 290 84 E-mail: [email protected]
Stockholm October 27, 2015 Formpipe Software AB The Board of Directors and the Managing Director
Formpipe Software AB (publ) Swedish company reg. no.: 556668-6605 Sveavägen 168 | Box 231 31 | 104 35 Stockholm T: +46 8 555 290 60 | F: +46 8 555 290 99 [email protected] | www.formpipe.se
| Jul-Sep | Jan-Sep | ||||
|---|---|---|---|---|---|
| (SEK 000) | 2015 | 2014 | 2015 | 2014 | |
| Net Sales | 88 140 | 81 882 | 277 946 | 245 133 | |
| Sales expenses | -12 559 | -13 239 | -36 819 | -35 763 | |
| Other costs | -16 599 | -15 350 | -51 505 | -45 804 | |
| Personell costs | -51 155 | -44 717 | -162 065 | -140 054 | |
| Capitalized work for own account | 11 448 | 8 882 | 33 045 | 25 743 | |
| Operating profit/loss before depreciation/amortization | 19 275 | 17 458 | 60 602 | 49 255 | |
| and non-comparative items (EBITDA) | |||||
| Acquisition-related costs | -3 538 | -667 | -3 538 | -1 167 | |
| Depreciation/amortization | -13 030 | -11 470 | -38 572 | -31 436 | |
| Operating profit/loss (EBIT) | 2 707 | 5 322 | 18 492 | 16 653 | |
| Financial income and expenses | -1 406 | -2 086 | -4 189 | -5 893 | |
| Exchange rate differences | 1 139 | -522 | -1 311 | -526 | |
| Tax | -620 | -680 | -2 650 | -2 357 | |
| Net profit for the period | 1 820 | 2 034 | 10 343 | 7 876 | |
| Of which the following relates to: | |||||
| Parent company shareholders | 2 002 | 2 364 | 10 131 | 7 615 | |
| Shareholding with no controlling influence | -182 | -330 | 211 | 261 | |
| Other comprehensive income | |||||
| Translation differences | 3 393 | 1 150 | -1 843 | 7 767 | |
| Other comprehensive income for the period, net after tax | 3 393 | 1 150 | -1 843 | 7 767 | |
| Total comprehensive income for the period | 5 213 | 3 184 | 8 500 | 15 643 | |
| Of which the following relates to: | |||||
| Parent company shareholders | 5 395 | 3 514 | 8 288 | 15 382 | |
| Shareholding with no controlling influence | -182 | -330 | 211 | 261 | |
| EBITDA margin, % | 21,9% | 21,3% | 21,8% | 20,1% | |
| EBIT margin, % | 3,1% | 6,5% | 6,7% | 6,8% | |
| Profit margin, % | 2,1% | 2,5% | 3,7% | 3,2% | |
| Earnings per share attributable to the parent company's shareholders dur ing |
|||||
| the period (SEK per share) | |||||
| - before dilution | 0,04 | 0,05 | 0,20 | 0,15 | |
| - after dilution | 0,04 | 0,05 | 0,20 | 0,15 | |
| Average no. of shares before dilution, in 000 | 50 143 | 50 143 | 50 143 | 49 338 | |
| Average no. of shares after dilution, in 000 | 50 539 | 50 143 | 50 579 | 49 338 |
| Sep 30 | Dec 31 | ||
|---|---|---|---|
| (SEK 000) | 2015 | 2014 | 2014 |
| Intangible assets | 503 921 | 496 581 | 510 203 |
| Tangible assets | 3 839 | 3 582 | 4 217 |
| Financial assets | 1 415 | 1 407 | 1 432 |
| Deferred tax asset | 23 551 | 30 243 | 25 292 |
| Current assets (excl. cash equivalents) | 84 088 | 68 578 | 91 334 |
| Cash equivalents | 15 619 | 6 846 | 26 035 |
| TOTAL ASSETS | 632 434 | 607 237 | 658 513 |
| Equity | 316 095 | 287 459 | 307 562 |
| Shareholding with no controlling influence | 2 926 | 3 048 | 2 715 |
| Long-term liabilities | 159 495 | 171 707 | 162 515 |
| Current liabilities | 153 917 | 145 023 | 185 721 |
| TOTAL EQUITY AND LIABILITIES | 632 434 | 607 237 | 658 513 |
| Net interest-bearing debt (-) / cash (+) | -109 161 | -140 324 | -116 892 |
| Equity attributable to the parent company's shareholders | Share- | ||||||
|---|---|---|---|---|---|---|---|
| Other | Profit/loss | holdings with | |||||
| Share | contributed | Translation | brought | no controlling | |||
| (SEK 000) | capital | capital | reserves | forward | Total | influence | Total |
| Balance at January 1, 2014 | 4 893 | 178 568 | -2 701 | 83 300 | 264 060 | 2 787 | 266 847 |
| Comprahensive income | |||||||
| Net profit for the period | - | - | - | 7 615 | 7 615 | 261 | 7 876 |
| Other comprahensive income items | - | - | 7 767 | - | 7 767 | - | 7 767 |
| Total comprahensive income | - | - | 7 767 | 7 615 | 15 382 | 261 | 15 643 |
| Transaction with owners | |||||||
| Share issue | 121 | 7 446 | - | - | 7 567 | - | 7 567 |
| Employee warrant schemes | - | 450 | - | - | 450 | - | 450 |
| Total transaction with owners | 121 | 7 896 | - | - | 8 017 | - | 8 017 |
| Balance at September 30, 2014 | 5 014 | 186 464 | 5 066 | 90 915 | 287 459 | 3 048 | 290 507 |
| Balance at January 1, 2015 | 5 014 | 186 464 | 14 670 | 100 301 | 307 562 | 2 715 | 310 277 |
| Comprahensive income | |||||||
| Net profit for the period | - | - | - | 10 131 | 10 131 | 211 | 10 342 |
| Other comprahensive income items | - | - | -1 843 | - | -1 843 | - | -1 843 |
| Total comprahensive income | - | - | -1 843 | 10 131 | 8 288 | 211 | 8 499 |
| Transaction with owners | |||||||
| Employee warrant schemes | - | 245 | - | - | 245 | - | 245 |
| Total transaction with owners | - | 245 | - | - | 245 | - | 245 |
| Balance at September 30, 2015 | 5 014 | 186 709 | 12 827 | 110 432 | 316 095 | 2 926 | 319 021 |
| Jul-Sep | Jan-Sep | |||
|---|---|---|---|---|
| (SEK 000) | 2015 | 2014 | 2015 | 2014 |
| Cash flow from operating activities | ||||
| before working capital changes | 11 941 | 12 393 | 49 171 | 32 737 |
| Cash flow from working capital changes | -121 | -3 460 | -9 772 | -1 158 |
| Cash flow from operating activities | 11 820 | 8 932 | 39 399 | 31 578 |
| Cash flow from investing activities | -11 522 | -15 059 | -31 961 | -30 332 |
| Of which acquisition of business activities | - | -7 345 | - | -7 345 |
| Cash flow from financing activities | -3 199 | -5 596 | -17 931 | -14 918 |
| Cash flow for the period | -2 900 | -11 723 | -10 492 | -13 672 |
| Change in cash and cash equivalent | ||||
| Cash and cash equivalent at the beginning of the period | 18 519 | 18 467 | 26 035 | 20 269 |
| Translation differences | 1 | 103 | 77 | 250 |
| Cash flow for the period | -2 900 | -11 723 | -10 492 | -13 672 |
| Cash and cash equivalent at the end of the period | 15 619 | 6 847 | 15 619 | 6 846 |
| Free cash flow | 299 | 1 218 | 7 439 | 8 591 |
| (SEK 000) | 2013 Q4 | 2014 Q1 | 2014 Q2 | 2014 Q3 | 2014 Q4 | 2015 Q1 | 2015 Q2 | 2015 Q3 |
|---|---|---|---|---|---|---|---|---|
| Support and maintenance | 35 425 | 35 815 | 37 519 | 38 101 | 37 748 | 41 247 | 41 059 | 40 735 |
| Licenses | 19 465 | 13 649 | 17 178 | 12 977 | 28 600 | 17 617 | 20 884 | 17 025 |
| System revenue | 54 891 | 49 465 | 54 697 | 51 078 | 66 348 | 58 864 | 61 942 | 57 759 |
| whereof recurring revenue | 37 574 | 38 017 | 39 865 | 40 554 | 40 242 | 43 813 | 43 827 | 43 557 |
| Deliveries | 29 187 | 29 540 | 29 549 | 30 804 | 30 964 | 35 119 | 33 880 | 30 381 |
| Net sales | 84 078 | 79 005 | 84 246 | 81 882 | 97 312 | 93 983 | 95 822 | 88 140 |
| Sales expenses | -9 661 | -10 343 | -12 181 | -13 239 | -6 841 | -11 624 | -12 636 | -12 559 |
| Other costs | -15 710 | -15 151 | -15 304 | -15 350 | -16 733 | -16 443 | -18 463 | -16 599 |
| Personnel costs | -46 685 | -46 527 | -48 810 | -44 717 | -56 254 | -53 953 | -56 957 | -51 155 |
| Capitalized development costs | 8 459 | 8 187 | 8 674 | 8 882 | 11 410 | 10 696 | 10 901 | 11 448 |
| Total operating expenses | -63 598 | -63 834 | -67 620 | -64 423 | -68 417 | -71 324 | -77 155 | -68 866 |
| EBITDA | 20 480 | 15 171 | 16 626 | 17 458 | 28 896 | 22 659 | 18 667 | 19 275 |
| % | 24,4% | 19,2% | 19,7% | 21,3% | 29,7% | 24,1% | 19,5% | 21,9% |
| Items affecting comparability | - | - | -500 | -667 | - | - | - | -3 538 |
| Depreciation/amortization | -9 753 | -9 851 | -10 115 | -11 470 | -12 066 | -12 708 | -12 834 | -13 030 |
| EBIT | 10 727 | 5 320 | 6 011 | 5 322 | 16 829 | 9 952 | 5 833 | 2 707 |
| % | 12,8% | 6,7% | 7,1% | 6,5% | 17,3% | 10,6% | 6,1% | 3,1% |
From January 1, 2015, the Life Science business area is reported as a stand-alone segment. This business was previously a part of the segment Sverige. The acquired entity GXP Ltd is included in this segment as per the acqisition date July 1, 2014.
| jan-sep 2015 | ||||||
|---|---|---|---|---|---|---|
| Life | ||||||
| (SEK 000) | Sweden | Denmark | Science | Eliminations | Group | |
| Sales, external | 99 933 | 163 885 | 14 128 | - | 277 946 | |
| Sales, internal | 1 126 | 3 281 | - | -4 407 | - | |
| Total sales | 101 059 | 167 166 | 14 128 | -4 407 | 277 946 | |
| Costs, external | -67 484 | -131 835 | -18 025 | - | -217 344 | |
| Costs, internal | -3 281 | -1 126 | - | 4 407 | - | |
| Operating profit/loss before deprecia tion/amortization and one-off items (EBITDA) |
30 293 | 34 206 | -3 897 | - | 60 602 | |
| % | 30,0% | 20,5% | -27,6% | 21,8% |
| jan-sep 2014 | ||||||
|---|---|---|---|---|---|---|
| Life | ||||||
| (SEK 000) | Sweden | Denmark | Science | Eliminations | Group | |
| Sales, external | 85 064 | 153 891 | 6 178 | - | 245 133 | |
| Sales, internal | 314 | 2 554 | - | -2 868 | - | |
| Total sales | 85 378 | 156 445 | 6 178 | -2 868 | 245 133 | |
| Costs, external | -57 079 | -128 327 | -10 472 | - | -195 878 | |
| Costs, internal | -2 554 | -314 | - | 2 868 | - | |
| Operating profit/loss before deprecia tion/amortization and one-off items (EBITDA) |
25 745 | 27 804 | -4 294 | - | 49 255 | |
| % | 30,2% | 17,8% | -69,5% | 20,1% |
| 2011-01-01 | 2012-01-01 | 2013-01-01 | 2014-01-01 | 2015-01-01 | |
|---|---|---|---|---|---|
| 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-09-30 | |
| Number of outstanding shares at the beginning | |||||
| of the period | 12 004 504 | 12 233 647 | 48 934 588 | 48 934 588 | 50 143 402 |
| Share issue | 229 143 | 36 700 941 | - | - | - |
| Non-cash issue | - | - | - | 1 208 814 | - |
| Number of outstanding shares at the end of the period |
12 233 647 | 48 934 588 | 48 934 588 | 50 143 402 | 50 143 402 |
| jan-sep | ||
|---|---|---|
| 2015 | 2014 | |
| Net sales, SEK 000 | 277 946 | 245 133 |
| EBITDA, SEK 000 | 60 602 | 49 255 |
| EBIT, SEK 000 | 18 492 | 16 653 |
| Net profit for the period, SEK 000 | 10 343 | 7 876 |
| EBITDA margin, % | 21,8% | 20,1% |
| EBIT margin, % | 6,7% | 6,8% |
| Profit margin, % | 3,7% | 3,2% |
| Return on equity, %* | 6,3% | 5,7% |
| Return on working capital, %* | 8,2% | 6,5% |
| Equity ratio, % | 50% | 47% |
| Equity per outstanding share at the end of the period, SEK | 6,30 | 5,73 |
| Earnings per share - before dilution, SEK | 0,20 | 0,15 |
| Earnings per share - after dilution, SEK | 0,20 | 0,15 |
| Share price at the end of the period, SEK | 7,80 | 5,95 |
* Ratios including P&L measures are based on the most recent 12-month period
| Jul-Sep | Jan-Sep | |||
|---|---|---|---|---|
| (SEK 000) | 2015 | 2014 | 2015 | 2014 |
| Net sales | 8 462 | 8 921 | 25 555 | 26 716 |
| Operating expenses | ||||
| Sales expenses | -562 | -672 | -1 759 | -1 929 |
| Other costs | -2 115 | -2 349 | -7 958 | -8 738 |
| Personnel costs | -8 517 | -6 644 | -25 554 | -22 826 |
| Depreciation/amortization | -462 | -445 | -1 367 | -1 242 |
| Total operating expenses | -11 656 | -10 110 | -36 638 | -34 735 |
| Operating profit/loss | -3 195 | -1 189 | -11 083 | -8 019 |
| Result from participations in group companies | - | - | - | - |
| Other financial items | 876 | -957 | -135 | -1 011 |
| Tax | - | - | - | - |
| Net profit for the period | -2 319 | -2 146 | -11 218 | -9 030 |
| Sep 30 | Dec 31 | ||
|---|---|---|---|
| (SEK 000) | 2015 | 2014 | 2014 |
| Intangible assets | 3 746 | 4 656 | 4 466 |
| Tangible assets | 989 | 1 349 | 1 279 |
| Financial assets | 440 518 | 454 718 | 450 278 |
| Deferred tax asset | 6 440 | 7 898 | 6 440 |
| Current assets (excl. cash equivalents) | 23 019 | 22 748 | 23 461 |
| Cash and bank balances | 20 951 | 4 192 | 21 232 |
| TOTAL ASSETS | 495 662 | 495 561 | 507 157 |
| Restricted equity | 22 705 | 22 705 | 22 705 |
| Non-restricted equity | 193 092 | 191 533 | 204 065 |
| Total equity | 215 797 | 214 238 | 226 770 |
| Long-term liabilities | 132 243 | 143 122 | 139 196 |
| Current liabilities | 147 622 | 138 201 | 141 191 |
| TOTAL EQUITY AND LIABILITIES | 495 662 | 495 561 | 507 157 |
The total of license revenue and revenue from support and maintenance contracts.
Revenue of an annually recurring nature such as support and maintenance revenue and revenue from rental license agreement.
Earnings before depreciation, amortization, acquisition-related costs and other items of a one-off nature.
EBIT
Operating profit/loss
Cash flow from operating activities minus cash flow from investing activities excluding acquisitions.
Equity at the end of the period divided by the number of shares at the end of the period.
Profit/loss after tax as a percentage of average equity
Operating profit/loss as a percentage of average working capital (balance sheet total less non-interest bearing liabilities and cash and bank balances).
OPERATING MARGIN BEFORE DEPRECIATION AND AMORTIZATION (EBITDA MARGIN)
Earnings before depreciation, amortization, acquisition-related costs and other items of a one-off nature as a percentage of net sales.
Operating profit/loss as a percentage of net sales.
Net profit/loss after tax as a percentage of sales at the end of the period.
Equity as a percentage of the balance sheet total.
Net profit/loss after tax divided by the average number of shares during the period.
Net profit/loss after tax adjusted for dilution effects divided by the average number of shares after dilution during the period.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.